Evaluating noninvasive brain stimulation to treat overactive bladder in individuals with multiple sclerosis: a randomized controlled trial protocol
Abstract Background Multiple Sclerosis (MS) is an often debilitating disease affecting the myelin sheath that encompasses neurons. It can be accompanied by a myriad of pathologies and adverse effects such as neurogenic lower urinary tract dysfunction (NLUTD). Current treatment modalities for resolvi...
Main Authors: | Betsy H. Salazar, Kristopher A. Hoffman, John A. Lincoln, Christof Karmonik, Hamida Rajab, Santosh A. Helekar, Rose Khavari |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12894-023-01358-8 |
Similar Items
-
Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01) -
FREQUENCY OF DETRUSOR LEAK POINT PRESSURES AMONGST PATIENTS WITH URODYNAMIC DIAGNOSIS OF DETRUSOR OVERACTIVITY
by: Nadeem Ahmad, et al.
Published: (2019-08-01) -
The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01) -
A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure
by: Kwang Jin Ko, et al.
Published: (2019-03-01) -
Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)